We Make Medicine


At Teva Canada, we believe that all Canadians deserve access to innovative and affordable medications. We develop, produce and market generic pharmaceuticals, from diabetic agents to antibiotics, from heart medications to cancer treatments. We’ve been part of Canadian healthcare since 1965, when we began operations as one of the country’s first generic pharmaceutical companies. Today, we employ over 1,500 Canadians. We invest in facilities in this country—creating generic and brand-name medications. And we’re proud to be part of Teva Pharmaceutical Industries Ltd. Worldwide, Teva is the leader in generics, one of the top 10 pharmaceutical companies, active in 60 countries and a workplace of choice for 46,000 dedicated employees.

We are motivated by a passion to make a difference.


GM December 8, 2014

Doug Sommerville announces the launch of PrTeva-Erlotinib, a generic of PrTarceva®

"Teva Canada’s industry-leading oncology portfolio is helping to mitigate the rising costs of cancer treatment in Canada." > more

May 5, 2015

Teva Canada Chooses HPIC in Exclusive Agreement to Handle All Medication Donations

Health Partners International of Canada's (HPIC) mission is to increase access to medicine and to improve health in vulnerable communities around the world. > more